Trends and geographical variation in invasive pneumococcal infections in Finland

Peter Klemets1, Outi Lyytikäinen, Petri Ruutu

  • 1National Public Health Institute (KTL), Department of Infectious Disease Epidemiology, Helsinki, Finland.

Insights

Invasive pneumococcal infections (IPI) in Finland increased significantly from 1995-2002, with higher rates linked to increased blood culturing. These findings highlight the need for pneumococcal conjugate vaccines.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Invasive pneumococcal infections (IPI) represent a significant public health concern globally.
  • Understanding regional variations and temporal trends in IPI is crucial for effective disease control strategies.

Purpose of the Study:

  • To evaluate regional variations and trends in invasive pneumococcal infections (IPI) in Finland between 1995 and 2002.
  • To assess the correlation between IPI rates and laboratory culture sampling rates.
  • To determine the impact of vaccine-preventable serotypes on IPI incidence.

Main Methods:

  • Utilized national, population-based laboratory surveillance data from 1995-2002.
  • Analyzed data on blood and cerebrospinal fluid (CSF) cultures from all Finnish microbiology laboratories.
  • Correlated regional IPI incidence with blood and CSF culture rates and examined temporal trends.

Main Results:

  • Overall IPI incidence was 10.6/100,000, with significant regional variation.
  • IPI rates increased by 35.1% from 1995-2002, correlating with a 29.6% increase in blood culturing rates.
  • Vaccine-targeted serotypes caused a substantial proportion of IPIs in both children and adults.

Conclusions:

  • The true incidence of pneumococcal bacteraemia in Finland may be underestimated.
  • Increased blood culturing rates are associated with higher reported IPI rates.
  • Universal childhood pneumococcal conjugate immunization could yield significant public health benefits.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...